Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2010
12/14/2010US7850971 PSMA antibodies and protein multimers
12/14/2010US7850969 Apparatus for reducing secretory activity of leukocytes which comprises plastic housing, carriers, blood inlet/outlet nozzles and an antibody against Fas (CD95) that is linked to the carrier
12/14/2010US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders
12/14/2010US7850963 Vascular endothelial growth factor 2
12/14/2010CA2624847C Dermatitis treating agent
12/14/2010CA2558026C Hiv integrase inhibitors
12/14/2010CA2485641C Novel condensed imidazole derivatives
12/14/2010CA2470044C Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
12/14/2010CA2373433C Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
12/14/2010CA2366857C Phthalazine derivatives for treating inflammatory diseases
12/14/2010CA2365392C Vaccine preparation containing fatty acid as a constituent
12/14/2010CA2355939C Antihistaminic spiro compounds
12/14/2010CA2308116C Low-toxicity human interferon-alpha analog
12/09/2010WO2010141584A2 Antagonism of human formyl peptide receptor for treatment of disease
12/09/2010WO2010140973A1 Recombinantly produced allergens
12/09/2010WO2010140686A1 Emulsifying preparation
12/09/2010WO2010140685A1 Heterocyclic compound and hematopoietic stem cell amplifier
12/09/2010WO2010139531A1 Breakfast cereals containing probiotic micro organisms
12/09/2010WO2010139196A1 Human anti human interferon alpha antibody and use thereof
12/09/2010WO2010139180A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010WO2010139047A1 Reagents and methods for detecting influenza virus proteins
12/09/2010WO2010115836A4 Substituted piperidines as ccr3 antagonists
12/09/2010WO2010095911A3 Composition for enhancing immunity containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as an active ingredient
12/09/2010WO2010090873A3 Polypeptides and their use as adjuvants
12/09/2010US20100313298 Expression cassette, t-dna molecule, plant expression vector, transgenic plant cell as well as their use in the manufacturing of a vaccine
12/09/2010US20100313284 Means and methods for eliciting an immune response
12/09/2010US20100311944 Cyclosporine analogue mixtures and their use as immunomodulating agents
12/09/2010US20100311818 Diterpene modulator of macrophage phagosomal maturation
12/09/2010US20100311816 MCP-1 binding nucleic acids and use thereof
12/09/2010US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/09/2010US20100311799 Polycyclic antagonists of lysophosphatidic acid receptors
12/09/2010US20100311787 Compounds for inflammation and immune-related uses
12/09/2010US20100311779 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them
12/09/2010US20100311778 Chromane derivatives as trpv3 modulators
12/09/2010US20100311754 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase
12/09/2010US20100311753 C5aR ANTAGONISTS
12/09/2010US20100311745 1,3-dihydroisoindole derivatives
12/09/2010US20100311743 Azaindoles Useful as Inhibitors of Janus Kinases
12/09/2010US20100311741 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents
12/09/2010US20100311736 Pyridosulfonamide derivatives as p13 kinase inhibitors
12/09/2010US20100311733 Thiadiazinone derivatives
12/09/2010US20100311715 Alpha carbolines and uses thereof
12/09/2010US20100311709 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA [f]INDAZOLE-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
12/09/2010US20100311706 Method of treatment of allergic rhinitis
12/09/2010US20100311686 Nutraceutical composition and methods for preventing or treating multiple sclerosis
12/09/2010US20100311656 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
12/09/2010US20100311644 Isozyme-specific antagonists of protein kinase c
12/09/2010US20100311643 Use of glp-1 as a therapeutic agent
12/09/2010US20100311189 Novel Receptor Nucleic Acids and Polypeptides
12/09/2010US20100310690 Pharmaceutical product and analysis model for hormone replacement therapy for women and prevention of some cancers and uterine myomas
12/09/2010US20100310677 Stable amorphous calcium carbonate comprising phosphorylated amino acids
12/09/2010US20100310673 Substance and composition both capable of imparting heat resistance
12/09/2010US20100310635 Compositions and Methods for Regulating T-Cell Activity
12/09/2010US20100310603 TEM8 as an Adjuvant and Uses Thereof
12/09/2010US20100310602 Synthetic glucopyranosyl lipid adjuvants
12/09/2010US20100310595 Method of transfection and compositions therefor
12/09/2010US20100310594 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
12/09/2010US20100310590 Hypoallergenic variants of the major allergen from betula verrucosa pollen
12/09/2010US20100310588 Regulatory t cells suppress autoimmunity
12/09/2010US20100310587 Immunomodulatory compositions
12/09/2010US20100310582 Methods for inducing in vivo tolerance
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310573 Anti-cd4 antibody
12/09/2010US20100310562 System for delivery into xcr1 positive cell and uses thereof
12/09/2010US20100310549 Inhibitors of type 2 vascular endothelial growth factor receptors
12/09/2010US20100310548 Methods of Manufacturing a Biologic Using a Stable Storage Intermediate
12/09/2010US20100310547 Treatment of Inflammatory Diseases
12/09/2010US20100310537 Method for expanding hematopoietic stem cells using heterocyclic compound
12/09/2010US20100310535 Method for expanding hematopoietic stem cells using heterocyclic compound
12/09/2010US20100310533 Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens
12/09/2010US20100310528 Vector System for Site-Specific Integration
12/09/2010US20100310525 Wnt pathway stimulation in reprogramming somatic cells
12/09/2010US20100310520 Microorganisms for improving the health of individuals with disorders related to gluten ingestion
12/09/2010US20100310513 Bifidobacterial species
12/09/2010US20100310511 Determining disease or immune system features based on analysis of immune system characteristics
12/09/2010US20100310510 N-terminally chemically modified protein compositions and methods
12/09/2010US20100310503 Novel compositions and methods for cancer treatment
12/09/2010US20100310501 Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject
12/09/2010US20100310472 Dna sequence, and recombinant preparation of the grass pollen allergen lol p 4
12/09/2010US20100310470 Immunomodulatory polymeric antigens for treating inflammatory pathologies
12/09/2010US20100310465 Nano-devices having releasable seals for controlled release of molecules
12/09/2010US20100310464 Antibodies
12/09/2010US20100310458 Use of soluble ceacam8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis
12/09/2010US20100310455 Heterocyclic Ligands for Integrin Imaging and Therapy
12/09/2010US20100310454 Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and /or their cancerous counterpart
12/09/2010CA2763893A1 Antagonism of human formyl peptide receptor for treatment of disease
12/09/2010CA2763822A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010CA2763492A1 Biomaterials, compositions, and methods
12/09/2010CA2763075A1 Recombinantly produced allergens
12/09/2010CA2761733A1 Reagents and methods for detecting influenza virus proteins
12/09/2010CA2760655A1 Heterocyclic compounds and expansion agents for hematopoietic stem cells
12/08/2010EP2258849A1 Mammalian receptor proteins; related reagents and methods
12/08/2010EP2258842A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2258724A1 Modulating immune responses using multimerized anti-CD83 antibodies
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258718A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2258712A2 Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258415A2 Medical devices containing rapamycin analogs
12/08/2010EP2258400A2 Multivalent VLA-4 antagonists comprising polymer moieties
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 1172